UNH - CVS Health: Seizing Opportunity Amid Recent Declines
2024-04-15 12:52:47 ET
Summary
- CVS Health Corporation is set to report its Q1 earnings on May 1st with analysts expecting revenue of $89 billion and EPS of $1.70.
- The CVS Health share price has underperformed the S&P 500 Index by almost 20% YTD, presenting a buying opportunity due to its discounted valuation and potential for upside.
- The recent decline in CVS stock can be attributed to fears of lower-than-expected payment increases for Medicare Advantage Plans, but the decline may now be priced in.
Summary
CVS Health Corporation ( CVS ) is scheduled to report its Q1 earnings on May 1st, 2024. Analysts estimate revenue to come in around $89 billion and EPS of $1.70. Over the last 2 years, CVS has beat on both the top- and bottom-lines as management has delivered on most of its promises....
CVS Health: Seizing Opportunity Amid Recent Declines